NQWM
AZN icon

Northwest Quadrant Wealth Management’s AstraZeneca AZN Stock Holding History

Northwest Quadrant Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Hold
1,362
– – 0.05% 65
2026
Q1 		$269K Sell
1,362
-1
-0.1% -$193 0.06% 53
2025
Q4 		$251K Hold
1,363
– – 0.05% 60
2025
Q3 		$209K Buy
+1,363
New +$206K 0.04% 72
2025
Q2 		– Sell
-1,856
Closed -$273K – 71
2025
Q1 		$273K Buy
1,856
+16
+0.9% +$2.31K 0.06% 49
2024
Q4 		$241K Sell
1,840
-1
-0.1% -$140 0.05% 63
2024
Q3 		$287K Buy
1,841
+4
+0.2% +$646 0.07% 49
2024
Q2 		$286K Hold
1,837
– – 0.07% 47
2024
Q1 		$249K Sell
1,837
-248
-12% -$32.8K 0.06% 53
2023
Q4 		$281K Hold
2,085
– – 0.07% 48
2023
Q3 		$282K Buy
2,085
+7
+0.3% +$956 0.08% 41
2023
Q2 		$297K Sell
2,078
-12
-0.6% -$1.77K 0.08% 42
2023
Q1 		$290K Buy
2,090
+25
+1% +$3.36K 0.08% 43
2022
Q4 		$280K Hold
2,065
– – 0.09% 47
2022
Q3 		$226K Buy
2,065
+7
+0.3% +$888 0.07% 50
2022
Q2 		$270K Hold
2,058
– – 0.08% 48
2022
Q1 		$274K Buy
2,058
+14
+0.7% +$1.68K 0.08% 50
2021
Q4 		$238K Hold
2,044
– – 0.06% 57
2021
Q3 		$244K Sell
2,044
-115
-5% -$13.4K 0.07% 55
2021
Q2 		$260K Hold
2,159
– – 0.07% 52
2021
Q1 		$215K Buy
2,159
+18
+0.8% +$1.81K 0.07% 60
2020
Q4 		$215K Hold
2,141
– – 0.07% 56
2020
Q3 		$236K Buy
2,141
+9
+0.4% +$1K 0.09% 51
2020
Q2 		$226K Hold
2,132
– – 0.1% 48
2020
Q1 		$225K Buy
2,132
+21
+1% +$1.98K 0.1% 48
2019
Q4 		$211K Buy
+2,111
New +$199K 0.09% 65

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northwest Quadrant Wealth Management's AZN Position: Q2 2026 in Review

Northwest Quadrant Wealth Management held its AstraZeneca (AZN) position steady in Q2 2026 at 1,362 shares worth $258K. The position accounts for 0.05% of the portfolio, ranked #65.

Northwest Quadrant Wealth Management first reported a position in AZN in Q4 2019 and has held it in 26 quarters since. The position peaked at $297K in Q2 2023. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Northwest Quadrant Wealth Management held 1,362 shares of AstraZeneca worth $258K as of Q2 2026.
  • Northwest Quadrant Wealth Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.05% of Northwest Quadrant Wealth Management's portfolio in Q2 2026, its #65 holding.
  • Northwest Quadrant Wealth Management first reported a position in AstraZeneca in Q4 2019 and has held it in 26 quarters since.
  • Northwest Quadrant Wealth Management's AstraZeneca position peaked at $297K in Q2 2023.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Northwest Quadrant Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.